Projects per year
Organization profile
Organisation profile
Our Department is composed of five Divisions and five Labs, including OB/GYN Ward (4A Ward): 40 beds; Labor Rooms: 10 beds; Delivery Rooms: 4 units; and Baby-Friendly Rooms: 8 beds. Five Divisions and five Labs are listed as below: Division of Gynecologic Oncology (Head: Dr. CY Chou） Division of Maternal-Fetal Medicine (Head: Dr. Lin Kang) Division of Prenatal Genetics (Head: PL Kuo) Division of General OB/GYN (Head: KF Hsu) OB/GYN Ultrasound Lab、 Fetal Medicine Center 、IVF Lab、 Molecular Genetics Diagnostic Lab 、 Female Urodynamics Lab Based on the infrastructure of five divisions and five labs, our Department is fully dedicated to the mission and development of teaching, research and service of Obstetrics and Gynecology. In total, our Department has a faculty of 15 attending staff, 6 residents, 8 technicians and 2 secretaries. For each year, our Department undertakes 3,000 gynecologic operations, and 1,100 deliveries on the average. Each operation and delivery are taken care and best served by our Attending Doctors.
Fingerprint Dive into the research topics where Department of Obstetrics Gynecology is active. These topic labels come from the works of this organisation's members. Together they form a unique fingerprint.
Pregnancy
Medicine & Life Sciences
Prenatal Diagnosis
Medicine & Life Sciences
Endometriosis
Medicine & Life Sciences
Uterine Cervical Neoplasms
Medicine & Life Sciences
Taiwan
Medicine & Life Sciences
Neoplasms
Medicine & Life Sciences
Fetus
Medicine & Life Sciences
Prenatal Ultrasonography
Medicine & Life Sciences
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Profiles
Projects 1995 2020
Research Output 1989 2019
A dose escalation study of trientine plus carboplatin and pegylated liposomal doxorubicin in women with a first relapse of epithelial Ovarian, Tubal, and peritoneal cancer within 12 months after platinum-based Chemotherapy
Huang, Y-F., Kuo, M. T., Liu, Y. S., Cheng, Y-M., Wu, P-Y. & Chou, C-Y., 2019 Jan 1, In : Frontiers in Oncology. 9, MAY, 00437.Research output: Contribution to journal › Article
Open Access
Trientine
Carboplatin
Platinum
Recurrence
Drug Therapy
1
Citation
(Scopus)
Akt inhibitor SC66 promotes cell sensitivity to cisplatin in chemoresistant ovarian cancer cells through inhibition of COL11A1 expression
Wu, Y. H., Huang, Y-F., Chen, C. C. & Chou, C-Y., 2019 Apr 1, In : Cell Death and Disease. 10, 4, 322.Research output: Contribution to journal › Article
Open Access
Ovarian Neoplasms
Cisplatin
Heterografts
CCAAT-Enhancer-Binding Protein-beta
Apoptosis
1
Citation
(Scopus)
An automated microfluidic system for selection of aptamer probes against ovarian cancer tissues
Liu, W. T., Lee, W. B., Tsai, Y. C., Chuang, Y. J., Hsu, K-F. & Lee, G. B., 2019 Jan 1, In : Biomicrofluidics. 13, 1, 014114.Research output: Contribution to journal › Article
SELEX Aptamer Technique
Microfluidics
Ovarian Neoplasms
cancer
Tissue